RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Lifecore Biomedical Stock

Lifecore Biomedical Net Income 2024

Lifecore Biomedical Net Income

-23.68 M USD

Ticker

LFCR

ISIN

US5147661046

WKN

899376

In 2024, Lifecore Biomedical's profit amounted to -23.68 M USD, a -76.21% increase from the -99.56 M USD profit recorded in the previous year.

The Lifecore Biomedical Net Income history

YEARNET INCOME (undefined USD)
2026e-3.74
2026e2.8
2025e-13.4
2024e-23.68
2023-99.56
2022-114.7
2021-32.7
2020-38.2
20190.4
201824.8
201710.6
2016-11.6
201513.5
201419.1
201322.6
201212.7
20113.9
20104
20097.7
200813.5
200729.2
20068.7
20055.4
20042.4

Lifecore Biomedical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Lifecore Biomedical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Lifecore Biomedical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Lifecore Biomedical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Lifecore Biomedical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Lifecore Biomedical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Lifecore Biomedical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Lifecore Biomedical’s growth potential.

Lifecore Biomedical Revenue, EBIT and net profit per share

DateLifecore Biomedical RevenueLifecore Biomedical EBITLifecore Biomedical Net Income
2026e167.59 M undefined21.49 M undefined-3.74 M undefined
2026e164.55 M undefined22.71 M undefined2.8 M undefined
2025e147.59 M undefined22.34 M undefined-13.4 M undefined
2024e127.91 M undefined3.32 M undefined-23.68 M undefined
2023103.27 M undefined-19.72 M undefined-99.56 M undefined
2022185.8 M undefined-3.5 M undefined-114.7 M undefined
2021171.5 M undefined5.4 M undefined-32.7 M undefined
2020160.1 M undefined-8.9 M undefined-38.2 M undefined
2019557.6 M undefined10.8 M undefined400,000 undefined
2018524.2 M undefined13.6 M undefined24.8 M undefined
2017469.8 M undefined17.2 M undefined10.6 M undefined
2016476.9 M undefined13.4 M undefined-11.6 M undefined
2015539.3 M undefined18.5 M undefined13.5 M undefined
2014476.8 M undefined20.2 M undefined19.1 M undefined
2013441.7 M undefined24.9 M undefined22.6 M undefined
2012317.6 M undefined14.6 M undefined12.7 M undefined
2011276.7 M undefined8 M undefined3.9 M undefined
2010238.2 M undefined8 M undefined4 M undefined
2009235.9 M undefined12.6 M undefined7.7 M undefined
2008238.5 M undefined15.2 M undefined13.5 M undefined
2007210.5 M undefined7.7 M undefined29.2 M undefined
2006232 M undefined9 M undefined8.7 M undefined
2005205.2 M undefined6 M undefined5.4 M undefined
2004192.1 M undefined4.1 M undefined2.4 M undefined

Lifecore Biomedical stock margins

The Lifecore Biomedical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Lifecore Biomedical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Lifecore Biomedical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Lifecore Biomedical's sales revenue. A higher gross margin percentage indicates that the Lifecore Biomedical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Lifecore Biomedical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Lifecore Biomedical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Lifecore Biomedical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Lifecore Biomedical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Lifecore Biomedical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Lifecore Biomedical Margin History

Lifecore Biomedical Gross marginLifecore Biomedical Profit marginLifecore Biomedical EBIT marginLifecore Biomedical Profit margin
2026e27.1 %12.82 %-2.23 %
2026e27.1 %13.8 %1.7 %
2025e27.1 %15.14 %-9.08 %
2024e27.1 %2.6 %-18.51 %
202327.1 %-19.1 %-96.41 %
202227.13 %-1.88 %-61.73 %
202129.45 %3.15 %-19.07 %
202024.61 %-5.56 %-23.86 %
201914.53 %1.94 %0.07 %
201814.94 %2.59 %4.73 %
201716.86 %3.66 %2.26 %
201614.01 %2.81 %-2.43 %
201512.13 %3.43 %2.5 %
201413.13 %4.24 %4.01 %
201314.22 %5.64 %5.12 %
201216.4 %4.6 %4 %
201116.88 %2.89 %1.41 %
201014.19 %3.36 %1.68 %
200914.54 %5.34 %3.26 %
200816.02 %6.37 %5.66 %
200715.39 %3.66 %13.87 %
200617.24 %3.88 %3.75 %
200515.59 %2.92 %2.63 %
200415.51 %2.13 %1.25 %

Lifecore Biomedical Aktienanalyse

What does Lifecore Biomedical do?

Landec Corp is a US-American company specialized in the development, manufacturing, and marketing of innovative products in the Agribusiness and Biotechnology sectors. It was founded in 1986 as a spin-off from the engineering faculty of Stanford University. The company follows a unique business model based on the integration of advanced technologies and biological processes. This aims to achieve sustainable agriculture that is both mindful of natural resources and achieves high yields. One of Landec's main divisions is the Fresh-Cut Products segment, where the company produces a variety of high-quality salads, vegetable, and fruit snacks that are distributed under the brand Eat Smart®. These products are known for their freshness, taste, and healthy nutritional values, and have gained high recognition in the USA. Another important business division of Landec is the Apio Packaging segment, specialized in the manufacturing and marketing of innovative packaging solutions for fresh fruits and vegetables. The packaging, distributed under the brand BreatheWay®, is equipped with a unique technology that regulates gas exchange within the package and extends the shelf life of the contents. In addition to these core segments, Landec is also active in the field of Biotechnology. Here, the company develops innovative products and technologies for use in human healthcare as well as the agricultural industry. An example of this is Apio's recently introduced whole plant juice called GreenWise™. Landec Corp is known for its innovation capabilities and its ability to develop new products and technologies. Throughout its history, the company has acquired a number of patents and awards and constantly strives to improve and advance its products. Overall, Landec Corp is a company that focuses on sustainability, innovation, and quality. With its unique business model and wide range of products and services, the company is well-positioned to continue growing and expanding its leadership position in the agriculture and biotechnology industry. Lifecore Biomedical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Lifecore Biomedical's Profit Margins

The profit margins of Lifecore Biomedical represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Lifecore Biomedical's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Lifecore Biomedical's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Lifecore Biomedical's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Lifecore Biomedical’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Lifecore Biomedical stock

How much profit has Lifecore Biomedical made this year?

Lifecore Biomedical has made -23.68 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -76.21% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Lifecore Biomedical publish its earnings?

Lifecore Biomedical publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Lifecore Biomedical?

The profits of Lifecore Biomedical are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Lifecore Biomedical?

You can learn more about the earnings of Lifecore Biomedical by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Lifecore Biomedical pay?

Over the past 12 months, Lifecore Biomedical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lifecore Biomedical is expected to pay a dividend of 0 USD.

What is the dividend yield of Lifecore Biomedical?

The current dividend yield of Lifecore Biomedical is .

When does Lifecore Biomedical pay dividends?

Lifecore Biomedical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lifecore Biomedical?

Lifecore Biomedical paid dividends every year for the past 0 years.

What is the dividend of Lifecore Biomedical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lifecore Biomedical located?

Lifecore Biomedical is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Lifecore Biomedical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lifecore Biomedical from 7/15/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/15/2024.

When did Lifecore Biomedical pay the last dividend?

The last dividend was paid out on 7/15/2024.

What was the dividend of Lifecore Biomedical in the year 2023?

In the year 2023, Lifecore Biomedical distributed 0 USD as dividends.

In which currency does Lifecore Biomedical pay out the dividend?

The dividends of Lifecore Biomedical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lifecore Biomedical

Our stock analysis for Lifecore Biomedical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lifecore Biomedical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.